Immuron (IMRN) Struggles After Announcing Trial Results
Immuron Limited (NASDAQ:IMRN) is a biotechnology company that provides a medicine to prevent diarrhea and is also developing similar medicines.
Immuron Ltd (IMRN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 45,782 | $34,909 | +135% | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
7 Best ASX Stocks to Buy Right Now
While the Federal Reserve cut interest rates in the US a couple of days back, in Australia, the trend appears to be moving in the opposite direction.
Immuron (IMRN) Posts 49% FY2025 Revenue Growth on Travelan Sales
Immuron Limited (NASDAQ:IMRN) is one of the best performing ASX stocks in 2025.
10 Best Performing ASX Stocks in 2025
Australian equities have delivered strong returns in 2025. The S&P/ASX 200 Index is up 7.15% year-to-date, and about 20% above the April 7 slump.
11 Best Australian Stocks to Buy According to Analysts
The tariffs announced by the United States have challenged the economic and market outlooks around the globe.
Market Movers Today: Zagg Inc (ZAGG), American Eagle Outfitters (AEO), Immuron Ltd (IMRN), Kroger Co (KR), and More
What happened: Shares of ZAGG (NASDAQ:ZAGG) have plunged today, down 19% as of 11:45 a.m. EST, after the company reported fourth-quarter earnings.
13G Filing: Courage Capital and Immuron Limited (IMRN)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing ...
Hedge Fund Resource Center